|Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families|
D Ford, DF Easton, M Stratton, S Narod, D Goldgar, P Devilee, DT Bishop, ...
The American Journal of Human Genetics 62 (3), 676-689, 1998
|Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations|
TR Rebbeck, HT Lynch, SL Neuhausen, SA Narod, L Van't Veer, ...
New England Journal of Medicine 346 (21), 1616-1622, 2002
|Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality|
SM Domchek, TM Friebel, CF Singer, DG Evans, HT Lynch, C Isaacs, ...
Jama 304 (9), 967-975, 2010
|Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group|
TR Rebbeck, T Friebel, HT Lynch, SL Neuhausen, L Van’t Veer, ...
Journal of clinical oncology 22 (6), 1055-1062, 2004
|Metabolic gene polymorphism frequencies in control populations|
S Garte, L Gaspari, AK Alexandrie, C Ambrosone, H Autrup, JL Autrup, ...
Cancer Epidemiology Biomarkers & Prevention 10 (12), 1239-1248, 2001
|Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers|
TR Rebbeck, ND Kauff, SM Domchek
Journal of the National Cancer Institute 101 (2), 80-87, 2009
|Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility.|
Cancer epidemiology, biomarkers & prevention: a publication of the American …, 1997
|Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program|
MS Brose, TR Rebbeck, KA Calzone, JE Stopfer, KL Nathanson, ...
Journal of the National Cancer Institute 94 (18), 1365-1372, 2002
|BRCA1 Mutations in Women Attending Clinics That Evaluate the Risk of Breast Cancer|
FJ Couch, ML DeShano, MA Blackwood, K Calzone, J Stopfer, ...
New England Journal of Medicine 336 (20), 1409-1415, 1997
|Type I and II endometrial cancers: have they different risk factors?|
VW Setiawan, HP Yang, MC Pike, SE McCann, H Yu, YB Xiang, A Wolk, ...
Journal of Clinical Oncology 31 (20), 2607, 2013
|Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers|
TR Rebbeck, AM Levin, A Eisen, C Snyder, P Watson, L Cannon-Albright, ...
Journal of the National Cancer Institute 91 (17), 1475-1479, 1999
|Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)|
N Mavaddat, D Barrowdale, IL Andrulis, SM Domchek, D Eccles, ...
Cancer Epidemiology, Biomarkers & Prevention 21 (1), 134-147, 2012
|Risk-reducing salpingo-oophorectomy for the prevention of BRCA1-and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study|
ND Kauff, SM Domchek, TM Friebel, ME Robson, J Lee, JE Garber, ...
Journal of clinical oncology 26 (8), 1331, 2008
|Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4|
TR Rebbeck, JM Jaffe, AH Walker, AJ Wein, SB Malkowicz
JNCI: Journal of the National Cancer Institute 90 (16), 1225-1229, 1998
|Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer|
SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ...
Nature genetics 45 (4), 371-384, 2013
|Comprehensive genomic characterization of long non-coding RNAs across human cancers|
X Yan, Z Hu, Y Feng, X Hu, J Yuan, SD Zhao, Y Zhang, L Yang, W Shan, ...
Cancer cell 28 (4), 529-540, 2015
|Assessment of cumulative evidence on genetic associations: interim guidelines|
JPA Ioannidis, P Boffetta, J Little, TR O’Brien, AG Uitterlinden, P Vineis, ...
International journal of epidemiology 37 (1), 120-132, 2008
|Approaching health disparities from a population perspective: the National Institutes of Health Centers for Population Health and Health Disparities|
RB Warnecke, A Oh, N Breen, S Gehlert, E Paskett, KL Tucker, N Lurie, ...
American journal of public health 98 (9), 1608-1615, 2008
|Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study …|
TR Rebbeck, T Friebel, T Wagner, HT Lynch, JE Garber, MB Daly, ...
Journal of clinical oncology 23 (31), 7804-7810, 2005
|Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer|
TR Rebbeck, N Mitra, F Wan, OM Sinilnikova, S Healey, L McGuffog, ...
Jama 313 (13), 1347-1361, 2015